Diagnostics & Research Stocks
Recent market-moving SEC filings and news across diagnostics & research companies, ranked by Wiseek's 1–10 importance score.
How Wiseek curates this list
Every item here is a high-importance (score ≥ 7) SEC filing or licensed news event for a diagnostics & research company, sourced from SEC EDGAR and licensed news wires and ranked by Wiseek's 1–10 importance score. The underlying source is linked from each article. See our methodology and editorial policy.
Related Healthcare industries
Biotech StocksMedical Device StocksPharmaceutical StocksHealth Tech StocksMedical Instrument StocksHealthcare Facility Stocks
See the full Healthcare sector feed.
Shareholders to Vote on Reverse Stock Split, Massive Share Increase, and New Equity Plans
CyPath® Lung Sales More Than Double Year-Over-Year in Q2 for bioAffinity Technologies
CyPath® Lung Sales Surge 200% Year-Over-Year, Boosting Commercial Momentum
Quantum Cyber Appoints President for Drone Subsidiary, Adds Independent Director
iSpecimen Amends $4M Offering, Reveals Deep Discount to Recent Private Placement and 126% Potential Dilution
DarioHealth Lands Major Arizona Insurer Deal via Amwell, Accessing Hundreds of Thousands of Lives
Roche Launches Axelios NGS System, Challenging Illumina's Core NovaSeq X Franchise
MDxHealth Receives Nasdaq Delisting Warning for Sub-$1.00 Bid Price
Prolaris Biopsy Test Shows Strong Prognostic Performance in 8,000+ Patient Meta-Analysis
Director Han Yusheng Buys $6.18M in Open Market Shares
Trinity Biotech Unveils Positive Clinical Data for CGM+ Solution, Addressing False Lows
Trinity Biotech's CGM+ Clinical Data Validates Multi-Sensor Tech, Tackles Major False Low Glucose Problem
Major Health Plan Expands DarioHealth Partnership, Potentially Tripling Revenue Opportunity
Quantum Cyber Finalizes $3.2M Acquisition of Manufacturing Facility for Defense Pivot
CareDx Finalizes Naveris Acquisition, Expands into High-Growth Oncology
CareDx Finalizes $170M Divestiture of Lab Products Division to Eurobio Scientific
Philips Partnership to Expand Veteran Lung Screening for bioAffinity, Sales Accelerate
bioAffinity Reports Accelerated CyPath® Lung Sales and New Pipeline Progress
ProPhase Labs Q1 Revenue Plunges 67% to $478K, Reports $(0.43) EPS Amid Restructuring
ProPhase Labs Reports Worsening Financials, Reaffirms Going Concern Doubt, and Details Highly Dilutive Financing
Advanced Biomed Sells Biomedical Subsidiary for $490K, Completing AI Pivot
Sera Prognostics Appoints Former Myriad Genetics CEO Mark Capone to Board
Trinity Biotech's Trinovium Secures Open Compute Project Membership for AI Data Center Liquid Cooling
Trinity Biotech Subsidiary Trinovium Joins Open Compute Project, Targets AI Data Center Liquid Cooling Market
Massive Dilution Looms: QUCY's $6M Convertible Could Add ~477M Shares; Company Buys CT Plant for $3.2M
Director Commits 9.99% Stake to Vote for Noble Africa Merger
BillionToOne Leases New Lab Space to Triple Oncology Capacity
Trinity Biotech Terminates Highly Dilutive $25M Equity Facility with Yorkville
GRAIL Faces Securities Class Action Over Alleged Misleading Disclosures in Failed NHS-Galleri Trial
Check-Cap Merger Partner MBody AI Expands Robotics Footprint to 11 US States and Enters Canada
Quantum Cyber Finalizes $3.2M Acquisition of US Drone Manufacturing Facility
DarioHealth Partners with Beluga Health to Integrate Clinical Care, Target New Markets
Quantum Cyber Dismisses Auditor Amidst Going Concern Warning, Appoints New Firm
ICON PLC Discloses $468M in New Impairments, Bridge Loan, and Debt Waivers in Annual Report
Quantum Cyber Board Approves Plan to Acquire Strategic Equity Stake in SpaceX
ENDRA Life Sciences Finalizes Definitive Merger Agreement with Noble Africa, Securing $50M Financing
ENDRA Life Sciences Secures $50M Financing, Pivots to Helium with Definitive Noble Africa Merger
ENDRA Finalizes Transformational Merger with Noble Africa, Securing $50M Capital Infusion at Premium Valuation
Board Member Files Intent to Sell $425K in Shares Amidst Merger Announcement
Agilent Raises $600M via 4.900% Senior Notes Due 2032 in Private Offering